GGrantIndex
← Leaderboards

Judith K Gwathmey

Rutgers Biomedical And Health Sciences

$17,596,554
Attributed
$18,774,118
Total exposure
15
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,774,118 · 15

By mechanism

R44$12,139,622 · 5
R01$3,861,347 · 2
R43$2,494,036 · 7
N43$279,113 · 1

Top collaborators

Most similar at Rutgers Biomedical And Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Cardiac Myocytes

Research focus

Cardiac MyocytesHeart FailureGene ExpressionDisease /Disorder ModelTransfectionCardiacHeartChelation TherapySarcoplasmic ReticulumUnited StatesCalciumHuman TissueCalcium Transporting AtpaseCalcium FluxSickle Cell AnemiaMolecular PathologyIron ChelationMyocardiumBioenergeticsIn VivoIronIron OverloadCardiotoxicityBinding Proteins

Grant awards (31)

Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization$589,278
R01 · FY2025 · HL
Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization$577,493
R01 · FY2024 · HL
Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization$584,829
R01 · FY2023 · HL
Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization$603,528
R01 · FY2022 · HL
Optimization of Iron Chelator Delivery System$1,475,189
R44 · FY2009 · HL · contact PI
BIOMEDICAL (APPLIED/EXPLORATORY)$279,113
N43 · FY2009 · HL · contact PI
Optimization of Iron Chelator Delivery System$2,425,024
R44 · FY2008 · HL · contact PI
Molecular Medicine Approaches to the Treatment of Vascular Disease$670,114
R43 · FY2008 · HL · contact PI
Vector Identification and Gene Delivery Approach in Pigs$1,457,861
R44 · FY2007 · HL · contact PI
Vector Identification and Gene Delivery Approach in Pigs$1,613,011
R44 · FY2006 · HL · contact PI
Animal Model of Ethanol-Induced Cardiomyopathy$970,816
R44 · FY2005 · AA
LV Volume Determinations: Mouse to Clinical Applications$286,571
R43 · FY2005 · HL
Genes Differentially Expressed During Heart Failure$175,000
R44 · FY2005 · HL
Vector Identification and Gene Delivery Approach in Pigs$102,500
R43 · FY2005 · HL
Assessment of a Telemetered PV-ECG System: Murine Models$61,500
R43 · FY2005 · HL
Assessment of a Telemetered PV-ECG System: Murine Models$30,248
R43 · FY2005 · HL
Vector Identification and Gene Delivery Approach in Pigs$25,248
R43 · FY2005 · HL
Genes Differentially Expressed During Heart Failure$1,260,000
R44 · FY2004 · HL
Animal Model of Ethanol-Induced Cardiomyopathy$826,316
R44 · FY2004 · AA
Assessment of a Telemetered PV-ECG System: Murine Models$227,782
R43 · FY2004 · HL
Vector Identification and Gene Delivery Approach in Pigs$188,782
R43 · FY2004 · HL
Genes Differentially Expressed During Heart Failure$1,230,000
R44 · FY2003 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$473,773
R01 · FY2002 · HL
Animal Model of Ethanol-Induced Cardiomyopathy$279,270
R43 · FY2002 · AA
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$461,830
R01 · FY2001 · HL
Optimization of Iron Chelator Delivery System$391,500
R43 · FY2001 · HL
OPTIMIZATION OF GENE DELIVERY IN ANIMAL HEARTS$706,405
R44 · FY2000 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$448,314
R01 · FY2000 · HL
TECHNOLOGIES TO IMPROVE THE UTILITY OF ANIMAL MODELS$230,521
R43 · FY2000 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$87,602
R01 · FY2000 · HL
HEART FAILURE--CALCIUM HOMEOSTASIS AND ENERGY RESERVE$34,700
R01 · FY2000 · HL